These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 15866699)
1. Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin. Zachary AA; Montgomery RA; Leffell MS Hum Immunol; 2005 Apr; 66(4):364-70. PubMed ID: 15866699 [TBL] [Abstract][Full Text] [Related]
2. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Zachary AA; Montgomery RA; Ratner LE; Samaniego-Picota M; Haas M; Kopchaliiska D; Leffell MS Transplantation; 2003 Nov; 76(10):1519-25. PubMed ID: 14657698 [TBL] [Abstract][Full Text] [Related]
3. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin. Yuan XP; Wang CX; Gao W; Fu Q; He XS Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369 [TBL] [Abstract][Full Text] [Related]
4. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience. Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614 [TBL] [Abstract][Full Text] [Related]
5. Desensitizing the broadly human leukocyte antigen-sensitized patient awaiting deceased donor kidney transplantation. Jordan SC; Reinsmoen N; Lai CH; Cao K; Kahwaji J; Peng A; Villicana R; Vo A Transplant Proc; 2012 Jan; 44(1):60-1. PubMed ID: 22310579 [TBL] [Abstract][Full Text] [Related]
6. Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients. Montgomery RA; Lonze BE; Jackson AM Curr Opin Organ Transplant; 2011 Aug; 16(4):439-43. PubMed ID: 21666478 [TBL] [Abstract][Full Text] [Related]
7. The presence of donor-specific antibodies in renal transplantation. Tozkir H; Sağiroğlu T; Kiliçarslan-Ayna T; Tan S; Çopuroğlu E; Sağiroğlu G; Sari G; Gürkan H; Sezer A Transplant Proc; 2012; 44(6):1667-9. PubMed ID: 22841240 [TBL] [Abstract][Full Text] [Related]
8. The role of the histocompatibility laboratory in desensitization for transplantation. Leffell MS; Zachary AA Curr Opin Organ Transplant; 2009 Aug; 14(4):398-402. PubMed ID: 19417655 [TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation. Lehrich RW; Rocha PN; Reinsmoen N; Greenberg A; Butterly DW; Howell DN; Smith SR Hum Immunol; 2005 Apr; 66(4):350-8. PubMed ID: 15866697 [TBL] [Abstract][Full Text] [Related]
10. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M Clin Transpl; 2007; ():219-26. PubMed ID: 18642453 [TBL] [Abstract][Full Text] [Related]
11. [Desensitization protocols in immunized living donor kidney transplant recipients]. Nocera A G Ital Nefrol; 2009; 26(4):499-515. PubMed ID: 19644839 [TBL] [Abstract][Full Text] [Related]
12. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Reinsmoen NL; Lai CH; Vo A; Cao K; Ong G; Naim M; Wang Q; Jordan SC Transplantation; 2008 Sep; 86(6):820-5. PubMed ID: 18813107 [TBL] [Abstract][Full Text] [Related]
13. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation. Kayler LK; Farber JL; Colombe B; LaCava D; Friedewald JJ; Ratner LE Transpl Int; 2006 Feb; 19(2):128-39. PubMed ID: 16441362 [TBL] [Abstract][Full Text] [Related]
14. Kinetics of cellular and humoral immunity in a successful case of positive crossmatch kidney transplantation: a case report. Tanimine N; Ide K; Yamashita M; Tanaka Y; Igarashi Y; Banshodani M; Tazawa H; Basnet NB; Doskali M; Onoe T; Tashiro H; Ohdan H Transplant Proc; 2011; 43(6):2411-4. PubMed ID: 21839279 [TBL] [Abstract][Full Text] [Related]
15. Posttransplant immunosuppression in highly sensitized patients. Akalin E Contrib Nephrol; 2009; 162():27-34. PubMed ID: 19001811 [TBL] [Abstract][Full Text] [Related]
17. A novel post-transplant alloantibody surveillance and intervention strategy that improves graft outcomes in sensitized renal transplant recipients. Kimball PM; King A Clin Transpl; 2011; ():369-72. PubMed ID: 22755433 [TBL] [Abstract][Full Text] [Related]
18. [HLA-incompatibility and kidney transplant: a question of desensitization]. Grosjean F G Ital Nefrol; 2011; 28(6):581. PubMed ID: 22167608 [No Abstract] [Full Text] [Related]
19. Effects of Two Preemptive Post-transplant Desensitization Regimens Upon Renal Allograft Survival and DSA Elaboration. Kimball PM; McDougan FA; King A Clin Transpl; 2014; ():197-203. PubMed ID: 26281145 [TBL] [Abstract][Full Text] [Related]
20. Lung transplantation across donor-specific anti-human leukocyte antigen antibodies: utility of bortezomib therapy in early graft dysfunction. Stuckey LJ; Kamoun M; Chan KM Ann Pharmacother; 2012 Jan; 46(1):e2. PubMed ID: 22202499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]